Buscar
Mostrando ítems 31-40 de 104
Jak2 46/1 Haplotype Is Associated With Jak2 V617f-positive Myeloproliferative Neoplasms In Brazilian Patients
(WILEY-BLACKWELLHOBOKEN, 2015)
Frequência da mutação JAK2V617F em pacientes com trombocitose no interior do RS
(Universidade Federal de Santa MariaBrasilCiências da SaúdeUFSMPrograma de Pós-Graduação em Ciências FarmacêuticasCentro de Ciências da Saúde, 2020-03-06)
Myeloproliferative neoplasms (MPN) are unique hematopoietic stem-cell disorders, resulting in an
increased proliferation of single or multilineage mature hematopoietic cells. JAK2V617F mutation is a
diagnostic ...
Cytogenetics, JAK2 and MPL mutations in polycythemia vera, primary myelofibrosis and essential thrombocythemia
(Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular, 2011-12-01)
BACKGROUND: The detection of molecular and cytogenetic alterations is important for the diagnosis, prognosis and classification of myeloproliferative neoplasms. OBJECTIVE: The aim of this study was to detect the following ...
Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase
(Elsevier, 2017)
Rearrangements of FGFR1 result in the 8p11 myeloproliferative syndrome, a group of rare diseases that features a myeloproliferative neoplasm (MPN) that commonly progresses to lymphoblastic leukemia/lymphoma or acute myeloid ...
JAK2 V617F Mutation Prevalence in Myeloproliferative Neoplasms in Pernambuco, Brazil
(Mary Ann Liebert IncNew RochelleEUA, 2012)